Predictive effect of PD-L1 expression for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatment for non-small cell lung cancer: A meta-analysis
Binbin Zhang, Yi Liu, Sijing Zhou, Huihui Jiang, Ke Zhu, Ran Wang
Topics & Concepts
NivolumabAtezolizumabMedicinePembrolizumabHazard ratioInternal medicineOncologyPD-L1Lung cancerMeta-analysisBiomarkerCochrane LibraryImmunotherapyCancerConfidence intervalBiochemistryChemistryCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsPancreatic and Hepatic Oncology Research